Intrinsic Value of S&P & Nasdaq Contact Us

Zosano Pharma Corporation ZSAN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
35/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Zosano Pharma Corporation (ZSAN) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 6 Buy, 2 Hold.

ZSAN Analyst Ratings

Buy
8
Ratings
6 Buy
2 Hold
Based on 8 analysts giving stock ratings to Zosano Pharma Corporation in the past 3 months
Rating breakdown
Buy
6 75%
Hold
2 25%
75%
Buy
6 analysts
25%
Hold
2 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message